ArticleMedical science monitor : international medical journal of experimental and clinical research2024

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia.

Dinah V ParumsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.